Combination of VNS/RNS impact on ECoG
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 05/17/2019
Pipeline Type
New Therapeutic Devices
Phase Of Development
Sponsors and Collaborators
Univ of Colorado
Mechanism of Action
Mechanism Description
Responsive intracranial stimulation with concurrent VNS
Populations Tested In
Drug Resistant Partial Onset Epilepsy
Other Resources
Special FDA Designation
Nonprofit or Government Support
N/A
Nonprofit or Government Support Description
N/A
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A
Location of Clinical Trials
N/A
Clinical Trial link